Last news
Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

Voranigo® has been awarded the Prix Galien USA, the Prix Galien Poland and the Prix Galien Bridges Awards for Best Product for Orphan/Rare Diseases. These awards across several geographies recognize the progress represented by Voranigo® for patients...

Mantle "2025 RWApped": A Year of Unstoppable MoMNTum and Global RWA Expansion

Mantle "2025 RWApped": A Year of Unstoppable MoMNTum and Global RWA Expansion

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- In 2025, Mantle entered a new phase of its evolution. What began as a high-performance Layer-2 rapidly transformed into a full-stack on-chain financial ecosystem, uniting infrastructure, liquidity,...

BingX Introduces Major Copy Trading Upgrade, Marking 1.3 Billion Copy Orders

BingX Introduces Major Copy Trading Upgrade, Marking 1.3 Billion Copy Orders

PANAMA CITY, Dec. 8, 2025 /PRNewswire/ -- BingX, a leading cryptocurrency exchange and Web3 AI company, today announced a major upgrade to its copy trading, celebrating a milestone of 1.3 billion cumulative copy trading orders. The update introduces...

Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI

Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI

Latest release enables faster, more confident design decisions at scale with accelerated simulation, AI-powered, real-time feedback, and GPU-accelerated reduced order modeling TROY, Mich., Dec. 8, 2025 /PRNewswire/ -- Altair, a global leader in...

Global Shift Toward Trust: 2025 Employer Branding Creativity Awards Highlight New Talent Trends

Global Shift Toward Trust: 2025 Employer Branding Creativity Awards Highlight New Talent Trends

XISHUANGBANNA, China, Dec. 8, 2025 /PRNewswire/ -- As global competition for talent intensifies, organisations are increasingly elevating employer branding from a recruitment-focused activity to a core strategic capability. Authentic storytelling,...

HanchorBio Presents First-in-Human Data of HCB101 Monotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma at ASH 2025

HanchorBio Presents First-in-Human Data of HCB101 Monotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma at ASH 2025

Early Phase 1 monotherapy data demonstrate cytopenia-sparing safety, broad pharmacologic window, and early clinical activity in relapsed/refractory non-Hodgkin lymphoma (NHL) TAIPEI, SHANGHAI, and SAN FRANCISCO, Dec. 8, 2025 /PRNewswire/ --...

51Talk Online Education Group Announces New Share Repurchase Program

51Talk Online Education Group Announces New Share Repurchase Program

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, today announced that its board of directors has...

51Talk Online Education Group Announces Third Quarter 2025 Results

51Talk Online Education Group Announces Third Quarter 2025 Results

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the third...

menu
menu